43 results
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
16 May 24
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to
6:15am
as an innovative combination formulation approved by the U.S. FDA, and its efficacy in treating acne has been proven by clinical trials. Beimei Pharma will perform … portfolio and pipeline, including 4 approved drugs launched in the market, and several innovative drugs with global rights and independent intellectual
424B3
SLGL
Sol-Gel Technologies Ltd
4 Apr 24
Prospectus supplement
9:05am
into this prospectus.
Our Company
We are a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin
POS AM
SLGL
Sol-Gel Technologies Ltd
20 Mar 24
Prospectus update (post-effective amendment)
4:05pm
by reference into this prospectus.
Our Company
We are a dermatology company leveraging innovative approaches to develop pioneering treatments for patients
6-K
EX-99.1
SLGL
Sol-Gel Technologies Ltd
13 Mar 24
Sol-Gel Reports Full-Year 2023 Financial Results and 2023 - Corporate Highlights and Recent Developments
8:34am
ZIONA, Israel, March 13, 2024 (GLOBE NEWSWIRE) - Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company with an innovative pipeline
6-K
EX-99.1
cpf2zi1nqka0188awv
30 Nov 23
Current report (foreign)
7:10am
424B3
fyzdry htsa
9 Nov 23
Prospectus supplement
3:41pm
6-K
EX-99.1
auouu
9 Nov 23
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:15am
424B3
itw z3v785gp7f
10 Aug 23
Prospectus supplement
7:20am
6-K
EX-99.1
ow9cjrxxx1nnsvkuxzw
10 Aug 23
Sol-Gel Technologies Reports Second Quarter 2023 Financial Results and Provides Corporate Update
7:10am
6-K
EX-99.1
0cbafs i8bt
6 Jun 23
Sol-Gel and Searchlight Pharma Announce Licensing Agreements to
7:15am
424B3
r6551tums7uly8
12 May 23
Prospectus supplement
9:15am
6-K
EX-99.1
5x5ohmjd
12 May 23
Sol-Gel Technologies Reports First Quarter 2023 Financial Results and Provides
12:00am
6-K
EX-99.1
s79tnz bw1z0w
4 Aug 22
Sol-Gel Technologies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
9:32am
6-K
EX-99.1
lig9hfny
8 Jun 22
Current report (foreign)
7:15am
6-K
EX-99.1
uhcdcapln9busdid w4
16 May 22
Current report (foreign)
7:35am
6-K
EX-99.1
nhi5x 1e8j6jio
13 May 22
Sol-Gel Technologies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:05am
424B5
ym2klme16fxr7e26y
19 Apr 22
Prospectus supplement for primary offering
4:02pm
20-F/A
j159lcg
7 Apr 22
Annual report (foreign) (amended)
4:06pm